Cervical cancer trials in Australia
17 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Adelaide, QLD
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 1Taking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Darlinghurst, Nedlands
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Blacktown, Southport, Sydney
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 2Taking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Adelaide, Benowa, Birtinya, North Sydney
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Auchenflower, Heidelberg, Kurralta Park
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Camperdown, Chermside, Clayton, Hobart, Hyde Park
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Blacktown, Mount Kuring-Gai, St Leonards, Subiaco, Woolloongabba
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Birtinya, Blacktown, Brisbane, Camperdown, Concord, Gold Coast, Nedlands, New Lambton Heights, Sydney, Waratah
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Brisbane, Camperdown, Geelong, Sydney
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Clayton, Nedlands
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - No phaseTaking peopleFeasibility Study of Blood Biomarker Identification in Cervical Cancer
- Where
- Brisbane
- Age
- 18 years and over
- People
- 100
- Run by
- Queensland Centre for Gynaecological Cancer
See details and how to joinNCT07796672 - Phase 1Taking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Southport, Waratah
- Age
- 18 years to 75 years
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - Phase 1Taking peopleA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Where
- Bedford Park, Buderim, Darlinghurst, Southport, Subiaco, Wollongong, Woolloongabba
- Age
- 18 years and over
- People
- 168 worldwide
- Run by
- OncoNano Medicine, Inc.
See details and how to joinNCT06022029 - Phase 2Not yet taking people in AustraliaEffector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure
- Where
- Parkville
- Age
- 18 years to 26 years
- People
- 300 worldwide
- Run by
- National Institute of Hygiene and Epidemiology, Vietnam
See details and how to joinNCT06681636 - Phase 1Taking peopleStudy of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
- Where
- Bedford Park, Darlinghurst, Malvern, Nedlands, Randwick, Westmead
- Age
- 18 years and over
- People
- 48
- Run by
- Myeloid Therapeutics
See details and how to joinNCT05969041